Fakhry et al reported 2 nomograms for predicting outcomes for a patient with oropharyngeal cancer. One model predicts progression-free survival (PFS). The authors are from Johns Hopkins University.
Patient selection: oropharyngeal cancer, ECOG 0 or 1
Parameters:
(1) p16 status
(2) Zubrod/ECOG performance status
(3) T stage (T2, T3, T4)
(4) N stage (AJCC 8th edition)
(5) age in years
(6) number of pack years for cigarette smoking
(7) education
(8) percent weight loss in the past 6 months
(9) marital status
Parameter |
Finding |
Points |
p16 status and Zubrod status |
p16 positive, Zubrod 0 |
0 |
|
p16 positive, Zubrod 1 |
84.6 |
|
p16 negative, Zubrod 0 |
96 |
|
p16 negative, Zubrod1 |
100 |
T stage |
T2 or T3 |
0 |
|
T4 |
29.9 |
N stage |
N0 or N1 |
0 |
|
N2 or N3 |
77.8 |
age in years |
<= 50 years |
0 |
|
> 50 years |
65.2 |
pack years |
<= 10 |
0 |
|
> 10 |
49.5 |
education |
high school or less |
45.4 |
|
post high school |
0 |
weight loss |
< 5% |
0 |
|
>= 5% |
39.1 |
marital status |
partner |
0 |
|
no partner |
36.3 |
total score =
= SUM(points for all of the parameters)
Interpretation:
• minimum score: 0
• maximum score: 527.8
• The higher the score the worse the overall survival.
Score |
5-Year PFS Probability |
< 38 |
> 90% |
38 to 296 |
X = 2.621 - (0.01013 * (score)) |
296 to 482 |
X = (-0.000057301 * ((score)^2)) + (0.022452 * (score)) - 2.073 |
> 482 |
< 1% |
probability of 5-Year PFS =
= 1 / (1 + EXP((-1) * X))
Specialty: Hematology Oncology